CPT 11007 – Debridement of Infected Abdominal Wall with Removal of Prosthetic Mesh

Definition and Code Description

CPT 11007: “Debridement of infected skin, subcutaneous tissue, muscle and fascia of abdominal wall, with removal of prosthetic material or mesh.”

This code involves extensive surgical debridement of the abdominal wall structures due to infection, including all affected layers such as:

• Skin
• Subcutaneous tissue
• Muscle
• Fascia

Additionally, the procedure requires removal of any prosthetic material or mesh, typically used during prior abdominal wall reconstruction or hernia repair.

Let’s explore the clinical situations in which CPT 11007 becomes necessary and the key factors that guide its appropriate use.

1. Common Causes

• Infection following hernia repair: Mesh infection is one of the most frequent complications after ventral or incisional hernia repairs.
• Contaminated surgical field: When the wound becomes infected postoperatively due to contamination during or after surgery.
• Necrotizing soft tissue infections: Severe bacterial infections may necessitate radical debridement.
• Chronic draining sinus or abscess formation around previously placed mesh material.

2. Typical Patient Presentation

Patients requiring this procedure often present with:

• Persistent wound drainage
• Erythema and swelling of the surgical site
• Fever or systemic infection signs
• Pain or tenderness over the surgical area
• Visible or palpable mesh exposure

3. Clinical Goals

The main objectives of CPT 11007 are:

• Eliminate all necrotic and infected tissue
• Remove contaminated prosthetic material
• Restore wound integrity and prevent systemic sepsis
• Create a clean wound bed for secondary closure or future reconstruction

This CPT code is anatomically specific to the abdominal wall and includes:

• Skin
• Subcutaneous tissue
• Fascia
• Muscle

CPT 11007 applies only to the abdominal wall region. Similar debridement procedures involving other body regions (such as chest wall, back, or extremities) are reported with different codes (e.g., 11004–11006 for chest, back, or perineum).

Below is a generalized outline of how this procedure is typically performed:

1. Preoperative Preparation

• The patient is positioned supine, and the area is prepped and draped in sterile fashion.
• Broad-spectrum antibiotics may be administered preoperatively.
• The extent of infection is assessed clinically and, if necessary, via imaging.

2. Surgical Exposure

• The previous incision is reopened, or a new incision is made to access the infected area.
• Pus or drainage is evacuated.
• Wound cultures may be taken to guide antibiotic therapy.

3. Debridement Process

• All infected, necrotic, or nonviable tissue is sharply excised.
• This includes removal of skin, subcutaneous tissue, fascia, and muscle as required.
• The goal is to achieve clean, viable, bleeding tissue margins.

4. Mesh Removal

• The prosthetic mesh is carefully identified and completely removed.
• Often, the mesh is partially integrated into fibrotic or infected tissue, making its removal technically demanding.
• Mesh explanation is critical because retained infected prosthetic material can perpetuate infection.

5. Irrigation and Wound Management

• The wound is copiously irrigated with antiseptic or saline solutions.
• Depending on the infection’s severity, the wound may be left open for delayed closure, or negative pressure wound therapy (VAC) may be applied.

6. Postoperative Care

• Broad-spectrum antibiotics are continued.
• Serial wound inspections and debridements may be required.
• Definitive reconstruction or closure is delayed until the infection resolves.

Accurate documentation is vital to support CPT 11007. The operative note should include:

• Diagnosis – Clearly state infection involving the abdominal wall and prosthetic mesh.
• Extent of Debridement – Specify all layers involved (skin, subcutaneous tissue, fascia, muscle).
• Mesh Removal – Document the removal of prosthetic material explicitly.
• Tissue Viability – Describe the tissue condition and confirm debridement to healthy tissue.
• Wound Management – State whether the wound was left open, packed, or managed with VAC.
• Specimens Collected – Mention cultures or biopsies sent to pathology.
• Intraoperative Findings – Include description of abscesses, purulent drainage, necrosis, or sinus tracts.

Example Documentation Statement

“Complete excision and debridement of necrotic skin, subcutaneous tissue, fascia, and muscle of the lower abdominal wall performed. Infected prosthetic mesh was completely removed. The wound was irrigated and left open with VAC placement.”

Accurate coding and billing for CPT 11007 require a clear understanding of its inclusion criteria, related codes, and common documentation pitfalls.

1. Code Family

CPT 11007 is part of the extensive debridement code family (11004–11008):

CPT 11007 includes both debridement and mesh removal. Do not report 11008 in addition to 11007 for the same site.

2. Do Not Report Separately

You should not separately bill for:

• Simple wound closure (included)
• Removal of sutures or drains
• Wound cultures (considered integral)

3. Modifier Use

• Modifier 59 may be used if a separate, distinct procedure was performed on a different anatomical site.
• Modifier 22 (Increased Procedural Services) can be justified if the debridement was exceptionally extensive or technically difficult, and documentation must support this.

Proper modifier usage is crucial for accurate CPT 11007 reporting. Learn more in our comprehensive article, The Role of Modifiers in Wound Care Coding Explained.

4. Common Bundling Issues

• CPT 11007 should not be billed with other debridement codes (e.g., 11042–11047) for the same wound.
• If multiple separate wound sites are treated (e.g., abdominal wall and leg), separate codes may be reported with appropriate modifiers.

Reimbursement for CPT 11007 is typically higher than standard wound debridement codes due to the complexity and inclusion of mesh removal. Payment rates vary by payer, region, and facility setting.

Approximate Medicare Reimbursement (as of 2025):

• Physician Fee Schedule (Facility Setting): ~$900–$1,200
• Hospital Outpatient (OPPS): Variable depending on Ambulatory Payment Classification (APC)

Always confirm with the latest CMS Physician Fee Schedule and payer policies for current rates.

The examples below demonstrate the correct application of CPT 11007 across a range of procedural circumstances.

Scenario 1

• Procedure: Extensive debridement of infected abdominal wound with mesh removal after ventral hernia repair.
• Correct Code: CPT 11007
• Rationale: Includes all debridement layers and prosthetic mesh removal.

Scenario 2

• Procedure: Simple debridement of skin and subcutaneous tissue only, no mesh removal.
• Correct Code: CPT 11042 (for subcutaneous tissue only).
• Rationale: 11007 would not apply without mesh or deeper tissue involvement.

Scenario 3

• Procedure: Debridement of abdominal wall infection, mesh retained.
• Correct Code: CPT 11005 (if deep debridement, no mesh removal).
• Rationale: 11007 specifically requires removal of prosthetic material.

Scenario 4

• Procedure: Removal of infected mesh only, no debridement of tissue.
• Correct Code: CPT 11008.
• Rationale: Mesh removal alone is separately reportable under 11008.

The following tips can help clinicians and medical coders apply CPT 11007 accurately, avoid common errors, and ensure complete documentation.

1. Mesh removal must be documented – Without this detail, CPT 11007 is not supported.
2. Depth of debridement matters – Include description of layers (muscle, fascia, etc.).
3. Photographic or intraoperative evidence – May assist in audit defense.
4. ICD-10 Coding Pairing – Include appropriate infection or complication codes such as:
   • T81.4XXA – Infection following a procedure
   • T85.79XA – Infection due to internal prosthetic device or graft
   • K43.7 – Ventral hernia with gangrene or infection
5. Avoid undercoding – Don’t default to superficial debridement codes when deeper structures are involved.

Several patient and procedural factors can increase the complexity of cases involving CPT 11007, making it crucial to evaluate these risks before and after surgery.

1. Mesh Infection Pathophysiology

Mesh infection occurs due to bacterial contamination during or after surgery. Once bacteria colonize the mesh surface, biofilm formation makes eradication with antibiotics alone nearly impossible.

2. Risk Factors

• Diabetes mellitus
• Obesity
• Smoking
• Contaminated surgical field (bowel injury)
• Recurrent hernia repair
• Poor wound care or hygiene

3. Surgical Decision-Making

Surgeons often face the dilemma of attempting to salvage the mesh versus complete removal. In most chronic infections, removal is mandatory, as biofilm prevents adequate sterilization.

Following CPT 11007, wound management typically includes:

• Negative Pressure Wound Therapy (VAC)
• Serial debridements until granulation tissue appears
• Reconstructive closure after infection resolution (may involve flap or biologic mesh)

CPT 11007 is often scrutinized during audits due to its relatively high reimbursement. Common issues include:

• Insufficient documentation of mesh removal
• Over-reporting when only superficial tissue was debrided
• Unbundling with other wound codes

To mitigate risk:

• Ensure operative reports explicitly describe mesh explantation.
• Confirm all wound layers are documented as involved.
• Retain culture results and postoperative wound care notes.

By offloading administrative work to virtual medical assistant services, clinicians can focus more on patient care without compromising billing accuracy.